Molecular Profiling
189 articles
Newly Diagnosed
What to Do If You Have Recently Been Diagnosed with Pancreatic Cancer You or someone you love has been diagnosed with pancreatic cancer. Now what? First, know that you are not alone in this overwhelming moment. No one should have to face pancreatic cancer without trusted resources and hope. Let’s Win is a go-to guide […]
Genetic Testing for All Pancreatic Cancer Patients
A study by Dr. Gloria Petersen’s research team has led to an official recommendation that all pancreatic cancer patients get genetic testing.
Earlier Detection of Pancreatic Cancer: A Marathon, Not A Sprint
Dino Verrelli of Project Purple joins with Dr. Diane Simeone on the PRECEDE Consortium to develop earlier detection and new pancreatic cancer treatments.
New Study to Get More Minorities Involved in Genetic Testing
Dr. Nicolette Rodriguez leads the REGENERATE study to find the best ways to get more Black and Latinx Americans genetic testing for cancer.
Let’s Win Announces Let’s Learn Webinar Series
Are you a health care professional who wants to know more about the risks, symptoms, and treatments for pancreatic cancer? Join our webinars!
Let’s Learn Webinar on Symptoms on March 25th
Are you a health care professional who wants to know more about the risks, symptoms, and treatments for pancreatic cancer? Join our Symptoms webinar to learn more!
Tumor Subtypes Potentially Provide Clues About Prognosis and Treatment
Drs. Andrew Aguirre and David Ting are teasing out the differences between pancreatic cancer subtypes, to get treatments that work better.
Pancreatic Cancer Research Builds Upon Strengths
The September 2023 AACR Special Conference on Pancreatic Cancer focused on the latest research in KRAS, chemotherapy, and cachexia, among other topics.
Progress and Promise—Research in 2023
What advances were made in 2023 for pancreatic cancer treatments? Where is research headed in the coming year?
Pancreatic Cancer Exceptional Responders and the Immune System Link
Dr. Vinod Balachandran looks at the immune system of exceptional responders–patients who respond extremely well to chemotherapy–for treatment clues.
Studying a New Approach for the Liquid Biopsy
Drs. Allyson Ocean and Ying-Hsiu Su lead a liquid biopsy pilot study looking for KRAS proteins in urine, to detect pancreatic cancer.